Sponsoring by the pharmaceutical industry can bias the results of drug studies

Drug studies financed by pharmaceutical companies frequently show positive results in favour of the sponsor. In the current issue of Deutsches Aerzteblatt International (Dtsch Arztebl Int 2010; 107(16): 279-85), a research group headed by the Chairman of the Drug Commission of the German Medical Association, Prof. Wolf-Dieter Ludwig, describes the influence of sponsoring on the results, protocol and quality of drugs studies...

Read the whole article on

More from